Annual Meeting: March 15 – 19, 2020
ToxExpo: March 16 – 18, 2020
Anaheim Convention Center, Anaheim, California
CNS drug discovery with translatable neuroscience technology
High attrition rates in CNS clinical trials is an indication that current testing is failing to predict safety/efficacy of compounds. NeuCyte supports early phases of drug discovery programs as well as the investigation of MOAs for experimental compounds. Based on the SynFire® technology, our human neural in vitro platforms are uniquely suited for assessing relevant higher order electrophysiology readouts, which allow for a better predictor of drug efficacy and potential CNS safety/toxicology.
@ToxExpo on Twitter
11190 Sunrise Valley Dr, Ste 300, Reston, VA 20191
Exhibitor Service Center
Anaheim Convention Center
800 W Katella Ave
Anaheim, CA 92802
Copyright 2018, a2z, Inc. All rights reserved.